Vaccines

The US Food and Drug Administration has approved its quadrivalent formulation of the Flublok influenza vaccine.

In the 10 years since the human papilloma virus (HPV) vaccine first became available, a series of new studies have come out showing just how effective the virus really is and how HPV vaccination rates can be improved in adolescents.

Researchers in a recent study investigated how mixed messages delivered by vaccine manufacturers may prevent women from receiving the safe and effective influenza vaccine during pregnancy.

Researchers recently studied the way people expressed their pro-vaccination and anti-vaccination opinions on Facebook to understand how people discuss and spread these views.

To assess factors associated with the likelihood that healthcare providers will accept seasonal influenza vaccine policy changes, Nova Scotia researchers examined the roles that their knowledge and attitude play in the matter.

Pharmacists are critical to expanding access to pandemic vaccination. However, little is known about the relationships and planning activities between public health programs and pharmacies.

The World Health Organization (WHO) recently met to establish new guidelines for the Southern Hemisphere’s 2017 influenza virus vaccine.

Recently, WHO published a paper outlining their decade-long initiative to increase access and regulate production of the influenza vaccine.

Thanks to the recently approved $1.1 billion in federal funding to support Zika virus-related efforts, various government agencies are ramping up efforts to develop novel vaccines designed to prevent infection.

Researchers at the University of Zurich and the University Hospital-Zurich have made a discovery that may contribute to the development of an effective HIV vaccine.

Kenneth Fife, MD, PhD, Professor of Medicine at Indiana University, School of Medicine, discusses whether or not his genital herpes vaccine, GEN-003, can protect against oral herpes.

The US Food and Drug Administration (FDA) is designating Sansaria PfSPZ, a malaria vaccine, to the “fast track” a move that will expedite the process for the drug, now in review.

A varicella outbreak that had occurred last year in Michigan is thought to be associated with riding on a school bus, which makes small, enclosed spaces, such as a school bus, a risk factor for both transmitting and acquiring airborne diseases.

A new, adaptable antibody, has been discovered by researchers at the Dana-Farber Cancer Institute that can mutate to neutralize a number of influenza strains.

Walgreens has partnered up again with the US Department of Health in an effort to improve rates of flu vaccination by providing over $10 million in free flu shot vouchers for Americans who are uninsured.

Nearly 900,000 people in the United States get pneumococcal pneumonia each year, resulting in about 400,000 hospitalizations annually.

An anxiously awaited vaccine for the fight against Zika may be available sooner rather than later—if its developers and federal health officials get their way.

Micaela Martinez, PhD, postdoctoral fellow in the Department of Ecology and Evolutionary Biology at Princeton University, discusses how vector seasonality can potentially be used to eradicate polio worldwide.

The US Food and Drug Administration (FDA) has approved the new influenza vaccines AFLURIA and AFLURIA QUADRIVALENT from Seqirus.

Micaela Martinez, PhD, postdoctoral fellow in the Department of Ecology and Evolutionary Biology at Princeton University, discusses how the poliovirus has not yet been eradicated despite preventive measures and deadlines.

A new study found that parents are more likely to support making human papillomavirus (HPV) vaccinations mandatory for school enrollment, if they are able to opt-out.

A new model of the within-host evolutionary arms race between viral pathogens and the adaptive immune responses intended to fight them suggests that vaccines based on genetically diverse sets of viral antigens may be more likely to stimulate the production of antibodies capable of neutralizing broad panels of virions.

Chlamydia has posed a healthcare challenge for clinicians due to the serious complications associated with it.

Researchers at St. Jude Children’s Research Hospital discovered that adjuvanted flu vaccines do not protect obese mice as they do their lean counterparts from flu infection.

Engineers at the Massachusetts Institute of Technology have developed a new type of customizable vaccines using messenger RNA that has proven to effectively combat a wide range of lethal pathogens when administered to mice, and might be able to reduce disease outbreak response time in the future.